Eosinophilic Esophagiti Market
8 targeted biological pathways transforming esophageal care in 2026 As 2026 begins, global gastroenterology networks are shifting away from generic dietary restrictions toward high-precision monoclonal antibody protocols that target the underlying Type 2 inflammatory response. This transition is marked by recent updates from the European Medicines Agency and the Indian Central Drugs Standard...
0 Σχόλια 0 Μοιράστηκε 850 Views 0 Προεπισκόπηση